Prot #ALLO-605-201: A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-647 and ALLO-605, an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients with Relapsed/Refractory Multiple Myelom

Project: Research project

Project Details

StatusFinished
Effective start/end date2/1/22 → 2/1/25

Funding

  • Covance Inc. ((OE) Prot #ALLO-605-201 // (OE) Prot #ALLO-605-201)
  • Allogene Therapeutics, Inc. ((OE) Prot #ALLO-605-201 // (OE) Prot #ALLO-605-201)